LLY

776.45

-2.39%↓

JNJ

152.33

+0.12%↑

ABBV

182.26

-2.5%↓

NVO

68.53

+1.17%↑

UNH

308.74

+2.11%↑

LLY

776.45

-2.39%↓

JNJ

152.33

+0.12%↑

ABBV

182.26

-2.5%↓

NVO

68.53

+1.17%↑

UNH

308.74

+2.11%↑

LLY

776.45

-2.39%↓

JNJ

152.33

+0.12%↑

ABBV

182.26

-2.5%↓

NVO

68.53

+1.17%↑

UNH

308.74

+2.11%↑

LLY

776.45

-2.39%↓

JNJ

152.33

+0.12%↑

ABBV

182.26

-2.5%↓

NVO

68.53

+1.17%↑

UNH

308.74

+2.11%↑

LLY

776.45

-2.39%↓

JNJ

152.33

+0.12%↑

ABBV

182.26

-2.5%↓

NVO

68.53

+1.17%↑

UNH

308.74

+2.11%↑

Search

Dr Reddy's Laboratories Ltd-ADR

Fechado

SetorSaúde

15.05 -1.76

Visão Geral

Variação de preço das ações

24h

Atual

Mín

14.96

Máximo

15.32

Indicadores-chave

By Trading Economics

Rendimento

1.8B

16B

Vendas

1.5B

85B

P/E

Médio do Setor

19.628

50.291

EPS

19.11

Rendimento de Dividendos

0.62

Margem de lucro

18.66

Funcionários

27,811

EBITDA

985M

25B

Recomendações

By TipRanks

Recomendações

Comprar

Previsão para 12 meses

+10.24% upside

Dividendos

By Dow Jones

Rendimento de Dividendos

Médio do Setor

0.62%

2.40%

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

10B

13B

Abertura anterior

16.81

Fecho anterior

15.05

Pontuação Técnica

By Trading Central

Confiança

Very Strong Bearish Evidence

Dr Reddy's Laboratories Ltd-ADR Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

9 de mai. de 2025, 18:56 UTC

Ganhos

Dr Reddy's Laboratories 4Q EPS INR19.11 >RDY

9 de mai. de 2025, 18:56 UTC

Ganhos

Dr Reddy's Laboratories 4Q Rev INR85.06B >RDY

23 de jan. de 2025, 17:46 UTC

Ganhos

Dr. Reddy's 3Q Net Attributable to Equity Holders of Parent Company INR14.13B

23 de jan. de 2025, 17:42 UTC

Ganhos

Dr. Reddy's 3Q Rev INR83.59B

5 de nov. de 2024, 11:01 UTC

Ganhos

Dr. Reddy's Laboratories 1H Rev INR156.89B Vs. INR136.19B >RDY

5 de nov. de 2024, 11:00 UTC

Ganhos

Dr. Reddy's Laboratories 1H Net INR26.47B Vs. Net INR28.825B >RDY

5 de nov. de 2024, 10:57 UTC

Ganhos

Dr. Reddy's Laboratories 2Q Net INR12.55B Vs. Net INR14.80B >RDY

5 de nov. de 2024, 10:57 UTC

Ganhos

Dr. Reddy's Laboratories 2Q Rev INR80.16B Vs. INR68.80B >RDY

Comparação entre Pares

Variação de preço

Dr Reddy's Laboratories Ltd-ADR Previsão

Preço-alvo

By TipRanks

10.24% parte superior

Previsão para 12 meses

Média 16.9 USD  10.24%

Máximo 16.9 USD

Mínimo 16.9 USD

Com base em 1 analistas de Wall Street que oferecem metas de preço de 12 meses para Dr Reddy's Laboratories Ltd-ADR - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Comprar

1 ratings

1

Comprar

0

Manter

0

Vender

Pontuação Técnica

By Trading Central

N/A / 13.84Suporte e Resistência

Curto Prazo

Very Strong Bearish Evidence

Médio Prazo

Weak Bullish Evidence

Longo Prazo

Weak Bearish Evidence

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Dr Reddy's Laboratories Ltd-ADR

Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Others segments. The company's Global Generics segment manufactures and markets prescription and over-the-counter finished pharmaceutical products that are marketed under a brand name or as a generic finished dosages with therapeutic equivalence to branded formulations, as well as engages in the biologics business. The PSAI segment manufactures and markets active pharmaceutical ingredients and intermediates, which are principal ingredients for finished pharmaceutical products. This segment also provides contract research services; and manufactures and sells active pharmaceutical ingredients and steroids in accordance with the specific customer requirements. The Others segment engages in developing therapies in the fields of oncology and inflammation; research and development of differentiated formulations; and provides digital healthcare and information technology enabled business support services. The company offers its products for various therapeutic categories primarily include gastro-intestinal, cardiovascular, anti-diabetic, dermatology, oncology, respiratory, stomatology, urology, and nephrology. Dr. Reddy's Laboratories Limited was incorporated in 1984 and is headquartered in Hyderabad, India.